Coskun et al., LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept, Mol
The 2025-2030 Dietary Guidelines for Americans updated the protein recommendation to 1.2 to 1.6 grams per kilogram of body weight, finally aligning official guidance with what the sports nutrition and body composition research has shown for years
Retatrutide 20mg Mid-content Retatrutide research peptide listing for non-clinical research applications
Trial exclusion patterns Phase 2 and Phase 3 retatrutide trials commonly excluded participants with a history of pancreatitis, medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2 (MEN 2), severe gastroparesis, recent major cardiovascular events, severe kidney impairment, type 1 diabetes (in the obesity studies), and pregnancy or breastfeeding